How It Works
Six partners - USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, DFID, and KOICA - came together to support this single challenge. The World Bank is also an affiliate of this program. Projects will be jointly selected through a unified application process. Successful innovators will be managed independently by one of two partners and funded and supported collectively as acommunity of innovatorsby all six partners.
Building a Community of Innovators
Partners will work with this community to foster learning and continued innovation. Awardees will receive support and networking assistance from each of the partners, engage with other innovators, and participate in high-level meetings including the Bill & Melinda Gates Foundation’s annual Grand Challenge meetings.
Types of Awards
We will invest in a portfolio of projects. Through this portfolio, we will seek groundbreaking innovations by providing:
- Seed Fundsto support the development and validation of ideas capable of impacting health outcomes for pregnant women and their babies in low-resource settings,
- Validation Fundsto introduce and validate the effectiveness of innovations to reach proof-of-concept, and
- Transition to Scale Fundsto develop, refine, and rigoursly test the impact ofintegrated solutions that have previously measured promising health outcomes in a controlled or limited setting and have the potential to credibly scale to improve the lives of millions of pregnant women and newborns in multiple countries. Transition funding is limited to integrated solutions that unite technology, service delivery, and demand.
What We’re Looking For
- A brief application.
- Rapid turnaround time. We aim to select awards within 5 months from the proposal submission deadline.
- Opportunities for shared learning and collaboration among innovators, funders and other public health experts.
- A review process designed to identify potentially groundbreaking ideas that show great promise.
- Substantially increase demand for and access to primary health interventions for women and newborns (for example, by at least 50 percent for interventions with low coverage);
- Substantially improve the quality of care as measured by health outcomes; and
- Improve and sustain healthy behavior.
- Be "off the beaten track," daring in premise, and clearly differentiated from standard practice;
- Enhance uptake, acceptability and provide forsustained use(potential for sustainability as defined as cost-recovery, sustained use, and sustainable impact);
- Below-costor highly cost-effective solutions;
- Have a strong likelihood of achieving asubstantial impacton one or more important adverse maternal, fetal, or neonatal health conditions;
- Bescalablein resource-poor settings;
- Be able to bemonitored, measured and evaluated.
All EOI must be written in English. EOI should be written clearly and with minimal jargon as reviewers will possess a variety of backgrounds and technical expertise.
• The EOI must be no longer than 3 pages. Any charts or tables included with 8 Submission and Review Process and Timeline the EOI will be considered within the page limits. References and citations to academic publications or other resources are not required but are encouraged. If included as a separate page as end notes, references and citations are not included in the page limits. Biographical descriptions and letters of support are not included in the stated page limits.
• All EOI must use a standard font no smaller than11-point font with one-inch margins.
• All EOI must be submitted through the online application platform, which can be accessed via the link found atwww.savinglivesatbirth.net/apply